Sean Lilienfeld

3.5k citations
21 papers · 2.5k indexed · 2 hit papers · h-index 14
Topics
Dementia and Cognitive Impairment Research (10 papers)Cholinesterase and Neurodegenerative Diseases (10 papers)Neurological Disorders and Treatments (8 papers)

In The Last Decade

Sean Lilienfeld

21 papers receiving 2.3k citations

Hit Papers

A 5-month, randomized, placebo-controlled trial of galant...200020262008201720002002200400600

Peers

Sean Lilienfeld
Comparison fields: 5 of 95
  • Pharmacology 1.2k
  • Psychiatry and Mental health 1.1k
  • Neurology 568
  • Physiology 547
  • Organic Chemistry 365
Replace Samantha Rogers with:
Samantha Rogers United Kingdom
Lawrence Friedhoff United States
Carlos Perdomo United States
Ara S. Khachaturian United States
Albrecht Stöffler Germany
John Grimley Evans United Kingdom
Christopher Ernesto United States
Hans Jörg Möbius Germany
Shelia Jin United States
Richard D. Hartman United States
Sean Lilienfeld relative to Samantha Rogers United Kingdom Samantha Rogers's profile →
Citations per field
00.5×1.5×2.5×
Samantha Rogers · 1×
Citations per year

Countries citing papers authored by Sean Lilienfeld

Since Specialization
Citations

This map shows the geographic impact of Sean Lilienfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Lilienfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Lilienfeld more than expected).

Fields of papers citing papers by Sean Lilienfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Lilienfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Lilienfeld. The network helps show where Sean Lilienfeld may publish in the future.

Co-authorship network of co-authors of Sean Lilienfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Lilienfeld. A scholar is included among the top collaborators of Sean Lilienfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Lilienfeld. Sean Lilienfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 36
3 1
4 12
5 35
6 59
7 149
8 39
9 27
10 37
11
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialbreakdown →
523
12 243
13 5
14 3
15 76
16 32
17 494
18 13
19 6
20
A 5-month, randomized, placebo-controlled trial of galantamine in ADbreakdown →
717

About Sean Lilienfeld

Sean Lilienfeld is a scholar working on Neurology, Psychiatry and Mental health and Pharmacology, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (10 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Neurological Disorders and Treatments (8 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Pharmacology (1.2k citations) and Neurology (568 citations). Sean Lilienfeld has collaborated with scholars based in United States, Germany and Finland. Frequent co-authors include G K Wilcock, Roger Bullock, Timo Erkinjuntti, Alexander Kurz, Changhai Ding, Julie Morris, Paul Kershaw, Pierre N. Tariot, Paul R. Solomon and C. V. Damaraju. Their work appears in journals such as The Lancet, Neurology and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026